CN101623245A - 犬猫防脱生命素 - Google Patents
犬猫防脱生命素 Download PDFInfo
- Publication number
- CN101623245A CN101623245A CN200910041081A CN200910041081A CN101623245A CN 101623245 A CN101623245 A CN 101623245A CN 200910041081 A CN200910041081 A CN 200910041081A CN 200910041081 A CN200910041081 A CN 200910041081A CN 101623245 A CN101623245 A CN 101623245A
- Authority
- CN
- China
- Prior art keywords
- extract
- hair
- dogs
- dog
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000282326 Felis catus Species 0.000 title claims abstract description 27
- 241000282472 Canis lupus familiaris Species 0.000 claims abstract description 73
- 239000000284 extract Substances 0.000 claims abstract description 47
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 26
- 240000001260 Tropaeolum majus Species 0.000 claims abstract description 12
- 239000001599 crocus sativus l. flower extract Substances 0.000 claims abstract description 12
- 229940002508 ginger extract Drugs 0.000 claims abstract description 12
- 235000020708 ginger extract Nutrition 0.000 claims abstract description 12
- 229940076591 saffron extract Drugs 0.000 claims abstract description 12
- 235000004424 Tropaeolum majus Nutrition 0.000 claims abstract description 11
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 11
- 229940055416 blueberry extract Drugs 0.000 claims abstract description 10
- 235000019216 blueberry extract Nutrition 0.000 claims abstract description 10
- 239000008213 purified water Substances 0.000 claims abstract description 9
- 241000219422 Urtica Species 0.000 claims abstract description 7
- 241000246044 Sophora flavescens Species 0.000 claims description 11
- 229930013930 alkaloid Natural products 0.000 claims description 11
- 235000020737 peppermint extract Nutrition 0.000 claims description 10
- 241001629703 Pueraria candollei var. mirifica Species 0.000 claims description 9
- 239000003755 preservative agent Substances 0.000 claims description 8
- 230000002335 preservative effect Effects 0.000 claims description 7
- 244000274883 Urtica dioica Species 0.000 claims description 5
- 235000009108 Urtica dioica Nutrition 0.000 claims description 5
- 150000003797 alkaloid derivatives Chemical class 0.000 claims description 5
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical group [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 4
- 239000004302 potassium sorbate Substances 0.000 claims description 4
- 235000010241 potassium sorbate Nutrition 0.000 claims description 4
- 229940069338 potassium sorbate Drugs 0.000 claims description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 4
- 235000010234 sodium benzoate Nutrition 0.000 claims description 4
- 239000004299 sodium benzoate Substances 0.000 claims description 4
- 201000004384 Alopecia Diseases 0.000 abstract description 19
- 210000004209 hair Anatomy 0.000 abstract description 19
- 210000003491 skin Anatomy 0.000 abstract description 19
- 230000002159 abnormal effect Effects 0.000 abstract description 11
- 210000003780 hair follicle Anatomy 0.000 abstract description 10
- 208000003251 Pruritus Diseases 0.000 abstract description 8
- 230000001737 promoting effect Effects 0.000 abstract description 8
- 230000007803 itching Effects 0.000 abstract description 7
- 230000017531 blood circulation Effects 0.000 abstract description 6
- 241000238631 Hexapoda Species 0.000 abstract description 5
- 238000003756 stirring Methods 0.000 abstract description 5
- 241000238876 Acari Species 0.000 abstract description 4
- ZSBXGIUJOOQZMP-UHFFFAOYSA-N Isomatrine Natural products C1CCC2CN3C(=O)CCCC3C3C2N1CCC3 ZSBXGIUJOOQZMP-UHFFFAOYSA-N 0.000 abstract description 4
- ZSBXGIUJOOQZMP-JLNYLFASSA-N Matrine Chemical compound C1CC[C@H]2CN3C(=O)CCC[C@@H]3[C@@H]3[C@H]2N1CCC3 ZSBXGIUJOOQZMP-JLNYLFASSA-N 0.000 abstract description 4
- 230000003266 anti-allergic effect Effects 0.000 abstract description 4
- 229930014456 matrine Natural products 0.000 abstract description 4
- 239000011782 vitamin Substances 0.000 abstract description 4
- 244000046146 Pueraria lobata Species 0.000 abstract description 3
- 235000010575 Pueraria lobata Nutrition 0.000 abstract description 3
- 230000036039 immunity Effects 0.000 abstract description 3
- 230000008439 repair process Effects 0.000 abstract description 3
- 239000000126 substance Substances 0.000 abstract description 3
- 235000015097 nutrients Nutrition 0.000 abstract description 2
- WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 abstract 1
- 231100000360 alopecia Toxicity 0.000 abstract 1
- 238000001914 filtration Methods 0.000 abstract 1
- 239000002932 luster Substances 0.000 abstract 1
- 229940105902 mint extract Drugs 0.000 abstract 1
- 231100000957 no side effect Toxicity 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 25
- 230000003676 hair loss Effects 0.000 description 18
- 208000024963 hair loss Diseases 0.000 description 17
- 239000000047 product Substances 0.000 description 15
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 12
- 241000196324 Embryophyta Species 0.000 description 12
- 210000004204 blood vessel Anatomy 0.000 description 12
- 230000000144 pharmacologic effect Effects 0.000 description 11
- 240000004371 Panax ginseng Species 0.000 description 10
- 235000008434 ginseng Nutrition 0.000 description 10
- 239000002075 main ingredient Substances 0.000 description 10
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 description 9
- 210000002216 heart Anatomy 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 8
- 238000001514 detection method Methods 0.000 description 8
- 239000000341 volatile oil Substances 0.000 description 8
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 7
- 244000078534 Vaccinium myrtillus Species 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 7
- 210000001736 capillary Anatomy 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 229930182494 ginsenoside Natural products 0.000 description 7
- 238000004128 high performance liquid chromatography Methods 0.000 description 7
- 229940041616 menthol Drugs 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 6
- 235000010208 anthocyanin Nutrition 0.000 description 6
- 239000004410 anthocyanin Substances 0.000 description 6
- 229930002877 anthocyanin Natural products 0.000 description 6
- 150000004636 anthocyanins Chemical class 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 6
- 235000020958 biotin Nutrition 0.000 description 6
- 239000011616 biotin Substances 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 6
- 239000008280 blood Substances 0.000 description 6
- CRPUJAZIXJMDBK-UHFFFAOYSA-N camphene Chemical compound C1CC2C(=C)C(C)(C)C1C2 CRPUJAZIXJMDBK-UHFFFAOYSA-N 0.000 description 6
- 230000006378 damage Effects 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 6
- 230000002107 myocardial effect Effects 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 201000004624 Dermatitis Diseases 0.000 description 5
- 241000282414 Homo sapiens Species 0.000 description 5
- 208000002193 Pain Diseases 0.000 description 5
- 238000003287 bathing Methods 0.000 description 5
- 235000002780 gingerol Nutrition 0.000 description 5
- 230000003648 hair appearance Effects 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 4
- XHXUANMFYXWVNG-ADEWGFFLSA-N (-)-Menthyl acetate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(C)=O XHXUANMFYXWVNG-ADEWGFFLSA-N 0.000 description 4
- OPFTUNCRGUEPRZ-QLFBSQMISA-N (-)-beta-elemene Chemical compound CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 4
- DOUMFZQKYFQNTF-WUTVXBCWSA-N (R)-rosmarinic acid Chemical compound C([C@H](C(=O)O)OC(=O)\C=C\C=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-WUTVXBCWSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 244000124209 Crocus sativus Species 0.000 description 4
- 235000015655 Crocus sativus Nutrition 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- 241000283973 Oryctolagus cuniculus Species 0.000 description 4
- 244000077923 Vaccinium vitis idaea Species 0.000 description 4
- 235000017606 Vaccinium vitis idaea Nutrition 0.000 description 4
- XCPQUQHBVVXMRQ-UHFFFAOYSA-N alpha-Fenchene Natural products C1CC2C(=C)CC1C2(C)C XCPQUQHBVVXMRQ-UHFFFAOYSA-N 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 229940076810 beta sitosterol Drugs 0.000 description 4
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 4
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 229930003935 flavonoid Natural products 0.000 description 4
- 150000002215 flavonoids Chemical class 0.000 description 4
- 235000017173 flavonoids Nutrition 0.000 description 4
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 4
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 4
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 4
- 229930007503 menthone Natural products 0.000 description 4
- 230000004089 microcirculation Effects 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 235000013974 saffron Nutrition 0.000 description 4
- 239000004248 saffron Substances 0.000 description 4
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 4
- 229950005143 sitosterol Drugs 0.000 description 4
- PFNFFQXMRSDOHW-UHFFFAOYSA-N spermine Chemical compound NCCCNCCCCNCCCN PFNFFQXMRSDOHW-UHFFFAOYSA-N 0.000 description 4
- MRMOZBOQVYRSEM-UHFFFAOYSA-N tetraethyllead Chemical compound CC[Pb](CC)(CC)CC MRMOZBOQVYRSEM-UHFFFAOYSA-N 0.000 description 4
- AIULWNKTYPZYAN-SFHVURJKSA-N (10)-Gingerol Chemical compound CCCCCCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 AIULWNKTYPZYAN-SFHVURJKSA-N 0.000 description 3
- AIULWNKTYPZYAN-UHFFFAOYSA-N 810gingerol Natural products CCCCCCCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 AIULWNKTYPZYAN-UHFFFAOYSA-N 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- PXRCIOIWVGAZEP-UHFFFAOYSA-N Primaeres Camphenhydrat Natural products C1CC2C(O)(C)C(C)(C)C1C2 PXRCIOIWVGAZEP-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 206010039491 Sarcoma Diseases 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 3
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 3
- 229940117893 apigenin Drugs 0.000 description 3
- 235000008714 apigenin Nutrition 0.000 description 3
- 229940102480 bilberry extract Drugs 0.000 description 3
- 235000019209 bilberry extract Nutrition 0.000 description 3
- 229930006739 camphene Natural products 0.000 description 3
- ZYPYEBYNXWUCEA-UHFFFAOYSA-N camphenilone Natural products C1CC2C(=O)C(C)(C)C1C2 ZYPYEBYNXWUCEA-UHFFFAOYSA-N 0.000 description 3
- 229960005233 cineole Drugs 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 3
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 3
- 230000035617 depilation Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 230000002964 excitative effect Effects 0.000 description 3
- 229940089161 ginsenoside Drugs 0.000 description 3
- YURJSTAIMNSZAE-HHNZYBFYSA-N ginsenoside Rg1 Chemical compound O([C@@](C)(CCC=C(C)C)[C@@H]1[C@@H]2[C@@]([C@@]3(C[C@@H]([C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)C)(C)CC1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O YURJSTAIMNSZAE-HHNZYBFYSA-N 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000035876 healing Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- KDADHLPROOOPIC-UHFFFAOYSA-N neokurarinol Natural products COc1cc(O)ccc1C1CC(=O)c2c(OC)cc(O)c(CC(CCC(C)(C)O)C(C)=C)c2O1 KDADHLPROOOPIC-UHFFFAOYSA-N 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 230000036284 oxygen consumption Effects 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 159000000001 potassium salts Chemical class 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- -1 urticoside Chemical compound 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- OPFTUNCRGUEPRZ-UHFFFAOYSA-N (+)-beta-Elemen Natural products CC(=C)C1CCC(C)(C=C)C(C(C)=C)C1 OPFTUNCRGUEPRZ-UHFFFAOYSA-N 0.000 description 2
- FQEQMASDZFXSJI-RWMBFGLXSA-N (-)-Anagyrine Natural products C([C@@H]12)CCCN1C[C@H]1C3=CC=CC(=O)N3C[C@@H]2C1 FQEQMASDZFXSJI-RWMBFGLXSA-N 0.000 description 2
- CULUKMPMGVXCEI-NXEZZACHSA-N (-)-N-Methylcytisine Natural products C12=CC=CC(=O)N2C[C@H]2CN(C)C[C@H]1C2 CULUKMPMGVXCEI-NXEZZACHSA-N 0.000 description 2
- NFLGAXVYCFJBMK-IUCAKERBSA-N (-)-isomenthone Chemical compound CC(C)[C@@H]1CC[C@H](C)CC1=O NFLGAXVYCFJBMK-IUCAKERBSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- 239000001605 (5-methyl-2-propan-2-ylcyclohexyl) acetate Substances 0.000 description 2
- BCIWKKMTBRYQJU-INIZCTEOSA-N (8)-Gingerol Chemical compound CCCCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 BCIWKKMTBRYQJU-INIZCTEOSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- ZEASWHWETFMWCV-UHFFFAOYSA-N 7-O-(2-O-Acetyl-6-O-Methyl-beta-D-glucuronoside)-4',5,7-Trihydroxyflavone Natural products C=1C(O)=C(O)C2=C(O)C(=O)C=C(C3C(CC4=C(O)C=C(O)C=C4O3)OC(=O)C=3C=C(O)C(O)=C(O)C=3)C=C2C=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 ZEASWHWETFMWCV-UHFFFAOYSA-N 0.000 description 2
- VSDUZFOSJDMAFZ-UHFFFAOYSA-N 8-gingerol Natural products COC(=O)C(N)CC1=CC=CC=C1 VSDUZFOSJDMAFZ-UHFFFAOYSA-N 0.000 description 2
- XVPBINOPNYFXID-JARXUMMXSA-N 85u4c366qs Chemical compound C([C@@H]1CCC[N@+]2(CCC[C@H]3[C@@H]21)[O-])N1[C@@H]3CCCC1=O XVPBINOPNYFXID-JARXUMMXSA-N 0.000 description 2
- FQEQMASDZFXSJI-UHFFFAOYSA-N Anagyrin Natural products C12CCCCN2CC2C3=CC=CC(=O)N3CC1C2 FQEQMASDZFXSJI-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 206010009944 Colon cancer Diseases 0.000 description 2
- CZSBHMFVVLYIQQ-RDVATZJHSA-N Crocin 2 Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(CO)C(O)C(O)C3O CZSBHMFVVLYIQQ-RDVATZJHSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 2
- NUPSHWCALHZGOV-UHFFFAOYSA-N Decyl acetate Chemical compound CCCCCCCCCCOC(C)=O NUPSHWCALHZGOV-UHFFFAOYSA-N 0.000 description 2
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 241000287828 Gallus gallus Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241000282412 Homo Species 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- CULUKMPMGVXCEI-UHFFFAOYSA-N N-methylcystisine Natural products C12=CC=CC(=O)N2CC2CN(C)CC1C2 CULUKMPMGVXCEI-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- SKPPEIDJGJGRGK-UHFFFAOYSA-N Panacen Natural products CCC1=CC=CC2=C1C1OC(C=C=CBr)CC1O2 SKPPEIDJGJGRGK-UHFFFAOYSA-N 0.000 description 2
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- ZZAFFYPNLYCDEP-HNNXBMFYSA-N Rosmarinsaeure Natural products OC(=O)[C@H](Cc1cccc(O)c1O)OC(=O)C=Cc2ccc(O)c(O)c2 ZZAFFYPNLYCDEP-HNNXBMFYSA-N 0.000 description 2
- 239000004783 Serene Substances 0.000 description 2
- 206010061373 Sudden Hearing Loss Diseases 0.000 description 2
- YSMRWXYRXBRSND-UHFFFAOYSA-N TOTP Chemical compound CC1=CC=CC=C1OP(=O)(OC=1C(=CC=CC=1)C)OC1=CC=CC=C1C YSMRWXYRXBRSND-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- YURJSTAIMNSZAE-UHFFFAOYSA-N UNPD89172 Natural products C1CC(C2(CC(C3C(C)(C)C(O)CCC3(C)C2CC2O)OC3C(C(O)C(O)C(CO)O3)O)C)(C)C2C1C(C)(CCC=C(C)C)OC1OC(CO)C(O)C(O)C1O YURJSTAIMNSZAE-UHFFFAOYSA-N 0.000 description 2
- 206010047139 Vasoconstriction Diseases 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003471 Vitamin B2 Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 2
- 229940088601 alpha-terpineol Drugs 0.000 description 2
- KQAZVFVOEIRWHN-UHFFFAOYSA-N alpha-thujene Natural products CC1=CCC2(C(C)C)C1C2 KQAZVFVOEIRWHN-UHFFFAOYSA-N 0.000 description 2
- FQEQMASDZFXSJI-YNEHKIRRSA-N anagyrine Chemical compound C([C@@H]12)CCCN1C[C@H]1C3=CC=CC(=O)N3C[C@H]2C1 FQEQMASDZFXSJI-YNEHKIRRSA-N 0.000 description 2
- ICFWMXKHGNCJTK-UHFFFAOYSA-N anagyrine Natural products O=C1C=CC=C2C3CC(CC4CCCCN4C3)N12 ICFWMXKHGNCJTK-UHFFFAOYSA-N 0.000 description 2
- 230000003656 anti-hair-loss Effects 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 2
- GJYKUZUTZNTBEC-UHFFFAOYSA-N beta-thujene Chemical compound CC1C=CC2(C(C)C)C1C2 GJYKUZUTZNTBEC-UHFFFAOYSA-N 0.000 description 2
- 229960002747 betacarotene Drugs 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- RFFOTVCVTJUTAD-UHFFFAOYSA-N cineole Natural products C1CC2(C)CCC1(C(C)C)O2 RFFOTVCVTJUTAD-UHFFFAOYSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 229920002770 condensed tannin Polymers 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 210000004351 coronary vessel Anatomy 0.000 description 2
- OXNHRKGZZFWUQZ-UHFFFAOYSA-N crocetin dimethyl ester Natural products COC(=O)C(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C(=O)OC OXNHRKGZZFWUQZ-UHFFFAOYSA-N 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 2
- CBEHEBUBNAGGKC-UHFFFAOYSA-N ginsenoside Rg1 Natural products CC(=CCCC(C)(OC1OC(CO)C(O)C(O)C1O)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5CC(OC6OC(CO)C(O)C(O)C6O)C34C)C CBEHEBUBNAGGKC-UHFFFAOYSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000003317 industrial substance Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 235000008777 kaempferol Nutrition 0.000 description 2
- XMUPAAIHKAIUSU-QRQCRPRQSA-N kurarinol Chemical compound C1([C@H]2OC=3C(C[C@@H](CCC(C)(C)O)C(C)=C)=C(O)C=C(C=3C(=O)C2)OC)=CC=C(O)C=C1O XMUPAAIHKAIUSU-QRQCRPRQSA-N 0.000 description 2
- 235000001510 limonene Nutrition 0.000 description 2
- 229940087305 limonene Drugs 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 2
- 210000004165 myocardium Anatomy 0.000 description 2
- CULUKMPMGVXCEI-VHSXEESVSA-N n-methylcytisine Chemical compound C12=CC=CC(=O)N2C[C@@H]2CN(C)C[C@H]1C2 CULUKMPMGVXCEI-VHSXEESVSA-N 0.000 description 2
- 210000001640 nerve ending Anatomy 0.000 description 2
- 235000001968 nicotinic acid Nutrition 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 229930015582 oxymatrine Natural products 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- DOUMFZQKYFQNTF-MRXNPFEDSA-N rosemarinic acid Natural products C([C@H](C(=O)O)OC(=O)C=CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 DOUMFZQKYFQNTF-MRXNPFEDSA-N 0.000 description 2
- TVHVQJFBWRLYOD-UHFFFAOYSA-N rosmarinic acid Natural products OC(=O)C(Cc1ccc(O)c(O)c1)OC(=Cc2ccc(O)c(O)c2)C=O TVHVQJFBWRLYOD-UHFFFAOYSA-N 0.000 description 2
- SGAWOGXMMPSZPB-UHFFFAOYSA-N safranal Chemical compound CC1=C(C=O)C(C)(C)CC=C1 SGAWOGXMMPSZPB-UHFFFAOYSA-N 0.000 description 2
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229940063675 spermine Drugs 0.000 description 2
- 208000017572 squamous cell neoplasm Diseases 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229920001864 tannin Polymers 0.000 description 2
- 235000018553 tannin Nutrition 0.000 description 2
- 239000001648 tannin Substances 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 230000025033 vasoconstriction Effects 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019164 vitamin B2 Nutrition 0.000 description 2
- 239000011716 vitamin B2 Substances 0.000 description 2
- VMYXUZSZMNBRCN-UHFFFAOYSA-N α-curcumene Chemical compound CC(C)=CCCC(C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-UHFFFAOYSA-N 0.000 description 2
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 2
- NZGWDASTMWDZIW-MRVPVSSYSA-N (+)-pulegone Chemical compound C[C@@H]1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-MRVPVSSYSA-N 0.000 description 1
- WTARULDDTDQWMU-RKDXNWHRSA-N (+)-β-pinene Chemical compound C1[C@H]2C(C)(C)[C@@H]1CCC2=C WTARULDDTDQWMU-RKDXNWHRSA-N 0.000 description 1
- UGJAEDFOKNAMQD-DVQDXYAYSA-N (-)-Falcarinol Natural products CCCCCCC\C=C\CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-DVQDXYAYSA-N 0.000 description 1
- WTARULDDTDQWMU-IUCAKERBSA-N (-)-Nopinene Natural products C1[C@@H]2C(C)(C)[C@H]1CCC2=C WTARULDDTDQWMU-IUCAKERBSA-N 0.000 description 1
- NFLGAXVYCFJBMK-BDAKNGLRSA-N (-)-menthone Chemical compound CC(C)[C@@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-BDAKNGLRSA-N 0.000 description 1
- OQHYAWWVSDRHNZ-XQAXOBNUSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO OQHYAWWVSDRHNZ-XQAXOBNUSA-N 0.000 description 1
- ZHAURGPSJHBQEI-GNFSWKDMSA-N (2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal;(3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO ZHAURGPSJHBQEI-GNFSWKDMSA-N 0.000 description 1
- PFTQIVMILQKDQN-PEBXRYMYSA-N (2s)-2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-8-[(2r)-5-hydroxy-5-methyl-2-prop-1-en-2-ylhexyl]-2,3-dihydrochromen-4-one Chemical compound C1([C@@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)C[C@@H](CCC(C)(C)O)C(=C)C)=CC=C(O)C=C1O PFTQIVMILQKDQN-PEBXRYMYSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- UGJAEDFOKNAMQD-MQNTZWLQSA-N (3S,9Z)-1,9-Heptadecadiene-4,6-diyn-3-ol Chemical compound CCCCCCC\C=C/CC#CC#C[C@@H](O)C=C UGJAEDFOKNAMQD-MQNTZWLQSA-N 0.000 description 1
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- LKZDFKLGDGSGEO-UHFFFAOYSA-N 2',8-Di-Me ether,7-O-beta-D-glucuronoside-2',5,7,8-Tetrahydroxyflavone Natural products OC1C(O)C(O)C(CO)OC1OC1C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)OC(CO)C(O)C1O LKZDFKLGDGSGEO-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- GDRKZARFCIYVCI-UHFFFAOYSA-N 4-Gingerol Chemical compound CCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 GDRKZARFCIYVCI-UHFFFAOYSA-N 0.000 description 1
- 108091006112 ATPases Proteins 0.000 description 1
- 102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 201000003126 Anuria Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 206010003497 Asphyxia Diseases 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 201000004569 Blindness Diseases 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010009168 Chyluria Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 101000862089 Clarkia lewisii Glucose-6-phosphate isomerase, cytosolic 1A Proteins 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 240000000491 Corchorus aestuans Species 0.000 description 1
- 235000011777 Corchorus aestuans Nutrition 0.000 description 1
- 235000010862 Corchorus capsularis Nutrition 0.000 description 1
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 1
- ATQIQIBBBWQWOT-QNFREAFUSA-N Crocin 4 Chemical compound COC(=O)C(\C)=C/C=C/C(/C)=C/C=C/C=C(/C)\C=C\C=C(/C)C(=O)OC1OC(CO)C(O)C(O)C1O ATQIQIBBBWQWOT-QNFREAFUSA-N 0.000 description 1
- ATQIQIBBBWQWOT-UHFFFAOYSA-N Crocin 4 Natural products COC(=O)C(=CC=CC(=CC=CC=C(/C)C=CC=C(/C)C(=O)OC1OC(CO)C(O)C(O)C1O)C)C ATQIQIBBBWQWOT-UHFFFAOYSA-N 0.000 description 1
- VMYXUZSZMNBRCN-AWEZNQCLSA-N Curcumene Natural products CC(C)=CCC[C@H](C)C1=CC=C(C)C=C1 VMYXUZSZMNBRCN-AWEZNQCLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 1
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 1
- 206010012689 Diabetic retinopathy Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 208000017701 Endocrine disease Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- UGJAEDFOKNAMQD-UHFFFAOYSA-N Falcarinol Natural products CCCCCCCC=CCC#CC#CC(O)C=C UGJAEDFOKNAMQD-UHFFFAOYSA-N 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 208000025309 Hair disease Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241001113425 Iridaceae Species 0.000 description 1
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- YXLKVASXUULQJH-LKUPDRCFSA-N Kuraridinol Natural products O=C(/C=C/c1c(O)cc(O)cc1)c1c(O)c(C[C@@H](C(=C)C)CCC(O)(C)C)c(O)cc1OC YXLKVASXUULQJH-LKUPDRCFSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 description 1
- 244000280293 Mentha haplocalyx Species 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 244000179970 Monarda didyma Species 0.000 description 1
- 235000010672 Monarda didyma Nutrition 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010052437 Nasal discomfort Diseases 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- PFTQIVMILQKDQN-FPTDNZKUSA-N Norkurarinol Natural products O=C1c2c(O)cc(O)c(C[C@@H](C(=C)C)CCC(O)(C)C)c2O[C@H](c2c(O)cc(O)cc2)C1 PFTQIVMILQKDQN-FPTDNZKUSA-N 0.000 description 1
- DKEYBVYGENRHLN-UHFFFAOYSA-N Norkurarinone Natural products CC(=CCC(Cc1c(O)cc(C)c2C(=O)CC(Oc12)c3ccc(O)cc3O)C(=C)C)C DKEYBVYGENRHLN-UHFFFAOYSA-N 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LIKQBKAAXQVRGO-UHFFFAOYSA-N Panasenoside Natural products OCC1OC(OC2C(O)C(O)C(CO)OC2Oc3cc(O)ccc3C4=CC(=O)c5c(O)cc(O)cc5O4)C(O)C(O)C1O LIKQBKAAXQVRGO-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- QFJUYMMIBFBOJY-UXZRXANASA-N Panaxatriol Chemical compound C[C@]1([C@H]2CC[C@@]3([C@@H]2[C@H](O)C[C@H]2[C@]3(C[C@@H](O)[C@H]3C(C)(C)[C@@H](O)CC[C@@]32C)C)C)CCCC(C)(C)O1 QFJUYMMIBFBOJY-UXZRXANASA-N 0.000 description 1
- VIXIMKLMEZTTTC-UHFFFAOYSA-N Panaxatriol Natural products CC1(C)CCCC(O1)C2CCC3(C)C2C(O)CC4C5(C)CCC(O)C(C)(C)C5C(O)CC34C VIXIMKLMEZTTTC-UHFFFAOYSA-N 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- WMHJCSAICLADIN-MVVLZTAMSA-N Picrocrocin Natural products O=CC=1C(C)(C)C[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)CC=1C WMHJCSAICLADIN-MVVLZTAMSA-N 0.000 description 1
- 241000224016 Plasmodium Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- YPWHZCPMOQGCDQ-UHFFFAOYSA-N Populnin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=CC(O)=CC=3)OC2=C1 YPWHZCPMOQGCDQ-UHFFFAOYSA-N 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- WTARULDDTDQWMU-UHFFFAOYSA-N Pseudopinene Natural products C1C2C(C)(C)C1CCC2=C WTARULDDTDQWMU-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000731396 Pueraria montana var. thomsonii Species 0.000 description 1
- NZGWDASTMWDZIW-UHFFFAOYSA-N Pulegone Natural products CC1CCC(=C(C)C)C(=O)C1 NZGWDASTMWDZIW-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000037111 Retinal Hemorrhage Diseases 0.000 description 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 241000258242 Siphonaptera Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000021712 Soft tissue sarcoma Diseases 0.000 description 1
- AAGFPTSOPGCENQ-UHFFFAOYSA-N Sophocarpin I Natural products C1CCC2CN3C(=O)C=CCC3C3C2N1CCC3 AAGFPTSOPGCENQ-UHFFFAOYSA-N 0.000 description 1
- IGXQFUGORDJEST-UHFFFAOYSA-N Sophocarpine Natural products O=C1C=CCC2C3CCCC4CCCC(CN12)C34 IGXQFUGORDJEST-UHFFFAOYSA-N 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- XRYVAQQLDYTHCL-IQMFZBJNSA-N Sophoraflavanone G Natural products C1([C@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)C[C@@H](CC=C(C)C)C(C)=C)=CC=C(O)C=C1O XRYVAQQLDYTHCL-IQMFZBJNSA-N 0.000 description 1
- VQYBAEAOOJBSTR-QHSBEEBCSA-N Sophoranol Chemical compound C([C@@H]12)CCC(=O)N1C[C@@]1(O)[C@H]3[C@@H]2CCCN3CCC1 VQYBAEAOOJBSTR-QHSBEEBCSA-N 0.000 description 1
- VQYBAEAOOJBSTR-AYRXBEOTSA-N Sophoranol Natural products O=C1N2[C@H]([C@@H]3[C@@H]4[C@](O)(C2)CCCN4CCC3)CCC1 VQYBAEAOOJBSTR-AYRXBEOTSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000223996 Toxoplasma Species 0.000 description 1
- ZKEKDTIKFVCKMW-UHFFFAOYSA-N Trifolin Natural products OCC1OC(Oc2cc(O)ccc2C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O ZKEKDTIKFVCKMW-UHFFFAOYSA-N 0.000 description 1
- 241000223104 Trypanosoma Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010064996 Ulcerative keratitis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 206010046996 Varicose vein Diseases 0.000 description 1
- 206010047163 Vasospasm Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- TTYVYRHNIVBWCB-VNQPRFMTSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] benzoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)C1=CC=CC=C1 TTYVYRHNIVBWCB-VNQPRFMTSA-N 0.000 description 1
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 208000037883 airway inflammation Diseases 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 102000016679 alpha-Glucosidases Human genes 0.000 description 1
- 108010028144 alpha-Glucosidases Proteins 0.000 description 1
- 229930016183 alpha-curcumene Natural products 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- USMNOWBWPHYOEA-UHFFFAOYSA-N alpha-thujone Natural products CC1C(=O)CC2(C(C)C)C1C2 USMNOWBWPHYOEA-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001453 anthocyanidins Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000001004 anti-acetylcholinic effect Effects 0.000 description 1
- 230000002804 anti-anaphylactic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002921 anti-spasmodic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- CZSBHMFVVLYIQQ-DRVLGOCHSA-N beta-D-gentiobiosyl beta-D-glucosyl crocetin Chemical compound O([C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)C(=O)C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CZSBHMFVVLYIQQ-DRVLGOCHSA-N 0.000 description 1
- VULLCGFNYWDRHL-YJOFKXFJSA-N beta-D-gentiobiosyl crocetin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](OC(=O)C(\C)=C\C=C\C(\C)=C\C=C\C=C(\C=C\C=C(/C)C(O)=O)/C)O[C@@H]1CO[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 VULLCGFNYWDRHL-YJOFKXFJSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 229930006722 beta-pinene Natural products 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 1
- 210000001011 carotid body Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 210000003756 cervix mucus Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 108091008690 chemoreceptors Proteins 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 230000035597 cooling sensation Effects 0.000 description 1
- 201000007717 corneal ulcer Diseases 0.000 description 1
- VULLCGFNYWDRHL-LZEXLXQKSA-N crocetin-mono-beta-D-gentiobiosyl ester Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)O VULLCGFNYWDRHL-LZEXLXQKSA-N 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- OXNHRKGZZFWUQZ-QORFUXSJSA-N gamma-Crocetin Chemical compound COC(=O)C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)C(=O)OC OXNHRKGZZFWUQZ-QORFUXSJSA-N 0.000 description 1
- LCWMKIHBLJLORW-UHFFFAOYSA-N gamma-carene Natural products C1CC(=C)CC2C(C)(C)C21 LCWMKIHBLJLORW-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940029988 ginseng preparation Drugs 0.000 description 1
- 229940107131 ginseng root Drugs 0.000 description 1
- 210000005086 glomerual capillary Anatomy 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000002710 gonadal effect Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001421 hyperglycemia Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000000199 inhibitory effect on leukemia Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 235000008800 isorhamnetin Nutrition 0.000 description 1
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-DTGCRPNFSA-N kaempferol 3-O-beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-DTGCRPNFSA-N 0.000 description 1
- LKZDFKLGDGSGEO-PABQPRPFSA-N kaempferol 3-O-beta-D-glucosylgalactoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O[C@H](CO)[C@H](O)[C@@H]1O LKZDFKLGDGSGEO-PABQPRPFSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- YXLKVASXUULQJH-VQHVLOKHSA-N kuraridinol Chemical compound COC1=CC(O)=C(CC(CCC(C)(C)O)C(C)=C)C(O)=C1C(=O)\C=C\C1=CC=C(O)C=C1O YXLKVASXUULQJH-VQHVLOKHSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 230000004297 night vision Effects 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- NMRPBPVERJPACX-UHFFFAOYSA-N octan-3-ol Chemical compound CCCCCC(O)CC NMRPBPVERJPACX-UHFFFAOYSA-N 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- 229930007459 p-menth-8-en-3-one Natural products 0.000 description 1
- KKAHGGJBKUXDNQ-KRWDZBQOSA-N panaxynol Natural products CCCCCCCC=CC=CCC#C[C@@H](O)C=C KKAHGGJBKUXDNQ-KRWDZBQOSA-N 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 239000012450 pharmaceutical intermediate Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 235000014786 phosphorus Nutrition 0.000 description 1
- WMHJCSAICLADIN-WYWSWGBSSA-N picrocrocin Chemical compound C1C(C)=C(C=O)C(C)(C)C[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 WMHJCSAICLADIN-WYWSWGBSSA-N 0.000 description 1
- 229930195126 picroside Natural products 0.000 description 1
- KEUKDVIGAVVGLF-RUYHYXBRSA-N picroside I Natural products OC[C@]12O[C@H]1[C@@H]3O[C@@H](O[C@@H]4O[C@H](COC(=O)C=Cc5ccccc5)[C@@H](O)[C@H](O)[C@H]4O)C=C[C@@H]3[C@H]2O KEUKDVIGAVVGLF-RUYHYXBRSA-N 0.000 description 1
- AKNILCMFRRDTEY-UHFFFAOYSA-N picroside II Natural products C1=C(O)C(OC)=CC(C(=O)OC2C3C(C(OC=C3)OC3C(C(O)C(O)C(CO)O3)O)C3(CO)OC32)=C1 AKNILCMFRRDTEY-UHFFFAOYSA-N 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- KAQKFAOMNZTLHT-OZUDYXHBSA-N prostaglandin I2 Chemical compound O1\C(=C/CCCC(O)=O)C[C@@H]2[C@@H](/C=C/[C@@H](O)CCCCC)[C@H](O)C[C@@H]21 KAQKFAOMNZTLHT-OZUDYXHBSA-N 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000001927 retinal artery Anatomy 0.000 description 1
- 210000001957 retinal vein Anatomy 0.000 description 1
- 201000009410 rhabdomyosarcoma Diseases 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000017509 safranal Nutrition 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N serine Chemical compound OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 206010041232 sneezing Diseases 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- AAGFPTSOPGCENQ-JLNYLFASSA-N sophocarpine Chemical compound C1CC[C@H]2CN3C(=O)C=CC[C@@H]3[C@@H]3[C@H]2N1CCC3 AAGFPTSOPGCENQ-JLNYLFASSA-N 0.000 description 1
- XRYVAQQLDYTHCL-CMJOXMDJSA-N sophoraflavanone G Chemical compound C1([C@@H]2CC(=O)C=3C(O)=CC(O)=C(C=3O2)C[C@@H](CC=C(C)C)C(C)=C)=CC=C(O)C=C1O XRYVAQQLDYTHCL-CMJOXMDJSA-N 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000009182 swimming Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 230000008718 systemic inflammatory response Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- DSNBHJFQCNUKMA-SCKDECHMSA-N thromboxane A2 Chemical compound OC(=O)CCC\C=C/C[C@@H]1[C@@H](/C=C/[C@@H](O)CCCCC)O[C@@H]2O[C@H]1C2 DSNBHJFQCNUKMA-SCKDECHMSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 150000004043 trisaccharides Chemical class 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000000143 urethritis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 208000027185 varicose disease Diseases 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种犬猫防脱生命素,它是由按一定比例混合的蓝莓提取物、欧荨麻提取物、苦参总碱提取物、印度水芹提取物、薄荷提取物、生姜提取物、野葛根提取物、人参提取物、西红花提取物和纯净水在常温下搅拌、过滤制作而成,能全面清洁毛发、杀虫、杀菌、除螨、止痒,通过促进狗、猫皮肤的血液循环,全面补充毛囊、毛发、皮肤所需的营养物质,提高皮肤、毛囊、毛发的免疫力,降低抗过敏性,增强皮肤、毛囊、毛发的修复功能,起到预防、治疗犬、猫类非正常脱毛的目的,通过实验证明,该生命素对犬类的非正常脱毛具有很好的抑制作用,而且能使毛质顺滑、光泽,并且对犬、猫不会产生任何副作用。
Description
技术领域
本发明涉及一种宠物洗浴用品,特别是一种有效预防、治疗犬、猫非正常脱毛的生命素。
背景技术
随着人们生活水平的提高,越来越多的宠物走进了现代人们的生活,成为众多家庭的“一员”,而犬类作为人类忠实的朋友,特别受到众多家庭的青睐。众所周知,犬类每年有两次换毛期,在春末秋末两季进行,换毛期为25天左右,这属于正常的换毛,而如果换毛时间超过25天以上或更长时间,或者全年不分季节不间断地大量脱毛,就属于非正常脱毛现象。追究其非正常脱毛的原因,大致有以下五种:
(1)、生理紊乱性脱毛:世界各地有300多种犬,分为玩赏犬、单猎犬、牧羊犬、群猎犬、梗犬、工作犬6个主要类别,因不同品种不同地区的犬有着很大的生理差异,这些生理差异会表现出明显的脱毛现象。
(2)、营养失调性脱毛:很多犬主认为自己为爱犬设计的食谱或选择的犬粮非常完美,其实犬主认为好的食谱不一定营养均衡,因为犬主毕竟不是动物营养师,同时好的犬粮是以大部分犬的营养需要设计的,并不是针对个别的犬类而设计,因此,当犬类缺乏皮肤、毛发所需的营养时,也会表现出大量的脱毛现象。
(3)、照管失误性脱毛:为爱犬洗澡是最基本的护理工作,但在洗澡时使用劣质洗浴剂或人用洗浴剂(由于人体皮肤与犬类的皮肤酸碱度不同,人用洗浴剂的PH值为7.5-8.5,犬类适用的洗浴剂的PH值为5.5-6.5),会破坏犬只毛囊油脂的分泌规律,造成毛囊退化致严重脱毛。
(4)、品种退化性脱毛:犬类虽然经过漫长的驯化但其本质仍然是犬,与人类共同生活往往使犬类失去了其所需的生活基本条件,如日照的时间、运动的强度、同类的社交等因素引致维生素、矿物质及内分泌失调,引致犬只的机体退化严重,造成严重的脱毛。
(5)、患皮肤病的犬只。
而犬类大量脱毛的危害主要体现在下面两个方面:
(1)、犬只大量的脱毛对儿童、老人影响较为严重,主要表现在接触性过敏,有的皮肤瘙痒,出现红疹,还有的鼻腔奇痒难耐、流鼻涕、打喷嚏等。
(2)、大量脱落的皮毛中还会迅速繁殖跳蚤、螨虫、弓形虫等,引致人类发生过敏性反应或引发皮痒、湿疹等皮肤病,不清洁、卫生。
由于以上的原因,犬类的非正常脱毛长期以来都困扰着养犬一族。到目前为止,国内外市场上尚未出现任何关于防止犬类非正常脱毛的药物,本发明正是在这种背景条件下针对犬、猫非正常脱毛而研发的防脱生命素。
发明内容
为了克服现有技术的不足,本发明提供一种能有效预防、治疗犬、猫类非正常脱毛的生命素。
本发明解决其技术问题所采用的技术方案是:
一种犬猫防脱生命素,其组分的重量百分比如下:
蓝莓提取物 10-14%
欧荨麻提取物 5-8%
苦参总碱提取物 2-6%
印度水芹提取物 10-15%
薄荷提取物 2-5%
生姜提取物 5-8%
野葛根提取物 8-12%
人参提取物 5-9%
西红花提取物 3-7%
加纯净水至100%。
其优选配方的重量百分比为:
蓝莓提取物 12%
欧荨麻提取物 6%
苦参总碱提取物 4%
印度水芹提取物 14%
薄荷提取物 4%
生姜提取物 7%
野葛根提取物 10%
人参提取物 7%
西红花提取物 5%
加纯净水至100%。
为了能使该生命素有较长的保质期,可以在其中加入重量百分比为0.1-0.3%的防腐剂,优选的重量百分比为0.1%。
本发明的有益效果是:蓝莓提取物中的花青素具有增加毛细血管的柔韧性、纯净促进血管膨胀和伸缩性、防止血管破裂等功效,对犬、猫的皮肤及毛质具有修复作用,有助于维持毛细血管完整性和稳定胶原质;欧荨麻提取物中的β-谷甾醇具有活血止痛、解毒的功效;苦参提取物具有抗过敏、免疫抑制、杀虫等作用,能降低过敏介质的释放;印度水芹提取物中的生物碱对动物有镇静作用;薄荷提取物具有刺激神经末梢之冷觉感受器,抗瘙痒等功效;生姜提取物能促进血液循环;野葛根提取物具有扩张血管,降低氧耗,改善血管收缩功能和促进血液微循环作用;人参提取物具有加强机体对有害因素的抵抗力,减弱某些毒物(苯、四乙铅、三甲酚磷酸等)对机体的伤害,促进损伤的愈合,能增强适应气温变化等能力的功效;西红花提取物对扁平细胞瘤和软组织肉瘤等都具有较强的抑制作用。
本发明将上述的药物按一定比例混合水溶制成犬猫防脱生命素,能全面清洁毛发、杀虫、杀菌、除螨、止痒,通过促进狗、猫皮肤的血液循环,全面补充毛囊、毛发、皮肤所需的营养物质,提高皮肤、毛囊、毛发的免疫力,降低抗过敏性,增强皮肤、毛囊、毛发的修复功能,起到预防、治疗犬、猫类非正常脱毛的目的,通过实验证明,该生命素对犬类的非正常脱毛具有很好的抑制作用,而且能使毛质顺滑、光泽,由于本发明的配方均为天然植物提取物,不包含任何的工业化工成分,对犬、猫不会产生任何副作用。
具体实施方式
配方的理论依据如下:
1、蓝莓提取物(Bilberry Extract)
植物来源:北欧高山寒冷地带,常绿低矮灌木植物叶子。
提取溶剂:75%食用乙醇&去离子水。
主要成分:花青素(甙)(Anthocyanidin)(EP/CN Standard)
产品介绍:中国越橘富含花青素,越橘花青素中的色素物质,主要为花青素-2-葡萄糖苷、花青素-3-木糖苷、花青素-3-半郛糖苷、花青素-2-鼠李糖苷、翠雀花-3-鼠李糖苷、翠雀花-5-葡萄糖苷、3-O-酰原花翠素、锦葵色素-3,5-二糖甙和3,3-二-酰原花萃素等。越橘花青素是高级医药中间体,有助于维持毛细血管完整性和稳定胶原质。花青素也是有力的抗氧化剂。
欧洲越橘又称蓝莓,主产于欧洲、北美洲。成熟的越橘果实富含黄铜类色素和用作抗氧化剂花青素。健康人或视力障碍病人单用越橘提取物或同时服用β-胡萝卜素和维生素E,可明显改善夜间视觉,对黑暗反应较快,眼暴露于亮光之后,能较快恢复视敏度。飞行员、司机、电脑操作人员服用越橘提取物,能有效提高视网膜调节能力,减轻光污染和光线刺激对视力造成的损伤。
药理作用:根据美国研究越橘的专家,毛瑞博士和日本三石严教授研究,天然越橘主要作用如下:
(1)增加毛细血管的柔韧性,可以纯净促进血管膨胀和伸缩性,防止血管破裂。
(2)提供抗氧化剂,能消除使血管硬化的自由基,预防动脉硬化,因此越橘被称誉为循环系统里的毛细血管的修理工。
(3)越橘既能强化眼睛里的毛细血管,当然也能强化身体其他器官组织里的毛细血管,达到预防各部器官血管病变。
(4)消灭自由基。当自由基侵害了细胞里的DNA去氧核糖核酸时,便是癌症的开始。越橘是一种抗氧化剂,它是自由基的克星,它是清除自由基的清道夫。
临床应用:
(1)可用于保护视力,防止失明、青光明、白内障、视网膜出血、改善近视、黄斑退化、糖尿病性网膜症、色素性视网膜炎及夜盲症等。
(2)强化脑血管、预防脑血管的病变、强化心肌血管、强壮冠状动脉、强化肾脏血管、预防肾小球毛细血管破裂而出现血尿、尿道炎及膀胱炎;强化静脉血管、预防静脉曲张、防治溃疡;防止动脉硬化;预防血栓的形成。
2、欧荨麻提取物(European nettle extract)
植物来源:为荨麻科植物欧荨麻的全草。夏、秋季采,切段晒干。
规格:β-谷甾醇0.8%
主要成分:含有抗坏血酸,乙酰胆碱,荨麻甙,β-谷甾醇等。
检测方法:GC
产品性状:黄棕色粉末
药理作用:
(1)全植株均可入药,味苦、辛,性温,小毒。
(2)有祛风定惊、活血止痛、消食通便和解毒的功效。鲜苗捣汁涂擦,可治荨麻疹。鲜草捣汁外敷,可治毒虫、毒蛇咬伤。
(3)全草用水煎服,可治胃腹疼痛、产后抽风、小儿惊风;适量煎汤擦洗,可治风湿性关节炎及其疼痛。根同黄麻根煎水洗,可治湿疹,对头部湿疹疗效较好;适量浸酒数日,服用可治风湿性关节炎及其疼痛。
3、苦参提取物Sophora Root extract
植物来源:本品为双子叶植物豆科(Leguminosae),苦参(Sophora flavescens Ait.)的干燥根。
规格:苦参总碱40%
主要成分:苦参碱(matrine)、氧化苦参碱(oxymatrine)、羟基苦参碱(sophor-anol)、N-甲基金雀花碱(N-methylcytisine)、安那吉碱(anagyrine)、膺靛叶碱(bap-iifoline)、脱氢苦参碱(sophocarpine)、d-异苦参碱(d-isomatrine)、苦参啶(kurarid-in)。去甲苦参酮(norkurarinone)、苦参啶醇(kuraridinol)、苦参醇(kurarinol)、新苦参醇(neo-kurarinol)、去甲苦参醇(norkurarinol)、异苦参酮,另含芒柄花黄素(f-ormononetin)。
检测方法:HPLC
产品性状:褐色浸膏
药理作用:苦参提取物有抗肿瘤、升白细胞、对心血管系统、平喘祛痰、安定、抗过敏、免疫抑制等作用,可清热燥湿,杀虫利尿。用于热痢、便血、黄疸尿闭、赤白带下、阴肿阴痒、湿疹、湿疮、皮肤瘙痒、疥癣麻风;外治滴虫性阴道炎。动物实验显示苦参碱具有抗心律失常、降血脂、中枢抑制、降低过敏介质的释放、抗溃疡等作用,此外还有抗菌作用以及对放射线引起的白细胞低下有防治作用。
4、印度水芹提取物(Indian cress extract)
植物来源:为伞形花科植物印度水芹的全草
规格:芹菜素10%
主要成分:芹菜素、芸香苷、水芹素、檞皮素、d-薴(C10H16,即柠檬烯)、瑟林烯(C15H24)挥发油、香柠檬内酯、绿原酸、咖啡酸、胡萝卜素、维生素C、烟酸、多种氨基酸、糖类、蛋白质、磷、铁等成分。
检测方法:HPLC
产品性状:棕色粉末
药理作用:芹菜素有降压作用,其作用主要是通过颈动脉体化学感受器的反射作用而引起。本品生物碱提取物对动物有镇静作用。肝经有热,肝阳上亢,烦热不安,眩晕;热淋,尿浊,小便不利或尿血;月经先期;胃热呕逆,饮食减少。现代用于高血压病、乳糜尿等。
5、薄荷提取物(peppermint extract)
植物来源:本品为唇形科薄荷属植物薄荷(Mentha haplocalyxBriq.)的干燥地上部分。
规格:薄荷醇10%
主要成分:挥发油,油中主成分为薄荷醇(Menthol),含量约77-78%,其次为薄荷酮(Menthone),含量为8-12%,还含乙酸薄荷脂(Menthyl acetate)、莰烯(Camphene)、柠檬烯(Limonene)、异薄荷酮(Isomenthone)、蒎烯(Pinene)、薄荷烯酮(Menthenone)、树脂及少量鞣质、迷迭香酸(Rosmarinicacid)。鲜茎叶含挥发油约1%,干茎叶含油1.3%-2%。油中主要含1-薄荷醇(1-menthol)约77%-87%,其次含1-薄荷酮(1-menthone)约10%。另含异薄荷酮(isomenthone)、胡薄荷酮(pulegone)、乙酸癸酯(decylacetate)、乙酸薄荷酯(menthyl acetate)、苯甲酸薄荷酯、α-蒎烯、戊醇-3、β-蒎烯、β-侧柏烯(β-thujene)、己醇-2、d-月桂烯(d-nyrcene)、宁烯、辛醇-3、桉叶素(cineole)和α-松油醇(α-terpineol)等。此外叶尚含苏氨酸(threonine)、丙氨酸、谷氨酸、天冬酰胺等多种游离氨基酸。据称含有树脂及少量鞣质和迷迭香酸(rosmarinic acid),还有多种黄酮类化合物。
检测方法:HPLC
产品性状:褐色粉末
药理作用:薄荷醇局部应用可治头痛、神经痛、瘙痒等。应用于皮肤,首先有凉感,以后有轻微刺灼感。此种凉感并非皮肤温度降低,而系刺激神经末梢之冷觉感受器所引起。薄荷醇、薄荷酮对离体兔肠有抑制作用,后者的作用较强。用小鼠作试验,对离体小肠,薄荷精油有解痉(抗乙酰胆碱)作用;但对整体小鼠的小肠内容物之推进速度并无显着影响,甚至有抑制倾向,故推测其健胃作用可能是由于其嗅、味感觉续发性引起的。薄荷醇的酒精溶液有防腐作用。它对呼吸道炎症有某些治疗作用,可能是由于其促进了分泌而去除了附着于粘膜上的粘液所致。薄荷酮之刺激性强于薄荷醇。
6、生姜提取物(Ginger extract)
植物来源:姜科多年生草本植物姜(Zingiber officinaleRosc.)的根茎。
规格:姜辣素5%
主要成分:挥发油和姜辣素类物质。挥发油如枸橼醛(Citral)、α-姜黄烯(α-Curcumene)、牛儿醛、1,8-桉叶油、莰烯等;姜辣素类如6-姜辣醇(6-Gingerol)、8-姜辣醇(8-Gingerol)、10-姜辣醇(10-Gingerol)、6-生姜酚(6-Shogaol)以及3-姜辣醇、4-生姜酚、6-生姜酚、10-生姜酚和姜酮等。
检测方法:HPLC
产品性状:浅棕黄色粉末
药理作用:生姜提取物是一种很好的肠胃保健产品,其主要成分姜辣素Gingerols能够通过促进血液循环等作用增强肠道的蠕动,治疗消化障碍、便秘、痢疾等多种消化道疾病;具有血清素诱发性降低体温的作用,能够减轻运动及感冒所引起的眩晕和头痛;姜辣素类成分还能抑制前列腺素的合成,可治疗风湿性关节炎和骨质增生。
7、野葛根提取物(Pueraria lobata extract)
植物来源:豆科植物野葛(Pueraria lobata(Willd.)Ohwi或甘葛藤Pueraria thomsonii Benth.)的干燥根。
规格:葛根素30%
主要成分:多种黄酮类成分,主要活性成分为大豆素(daidzein)、大豆甙(daidzin)、葛根素(puerarin)、葛根素-7-木糖甙(puerarin-7-xyloside)等。
检测方法:HPLC
产品性状:棕色粉末
药理作用:实验证明有扩张心脑血管,降低心肌氧耗,改善心肌收缩功能和促进血液微循环作用,用于治疗冠心病、视网膜动、静脉阻塞和突发性耳聋等微循环障碍病。其目前主要用于解表退热、生津、透疹、升阳止泻。用于外感发热头疼、高血压颈项强痛、消渴、麻疹不透。黄酮精品与粗品的药理作用相似,能改善微循环,扩张冠状动脉,增加脑和冠状动血流量,减慢心率,降低心肌耗氧指数而改善缺血心肌的代谢,还尚有抗血检素,TXA2提高PGI2及HDL的作用,并由此对抗血管痉孪,降低血小板集聚,临床主要用于治疗视网膜动静脉阻塞,突发性耳聋,心肌梗塞,冠心病,心绞痛,高血压等病症。
8、人参提取物(Ginseng Root extract)
植物来源:五加科植物人参(Panax ginseng C.A.Mey.)的干燥根。
规格:人参皂甙10%
主要成分:人参皂甙,少量挥发油。油中主要成份为人参烯(panacen,C15H24)0.072%。据报导从根中分离出皂甙类:人参皂甙A、B、C、D、E和F(panaxoside A、B、C、D、E、F)等。人参皂甙A(C42H72014),为人参皂甙Rg1(ginsenoside Rg1)。人参皂甙B和C水解后产生人参三醇(panaxatriol)皂甙元,人参皂甙D、E和F水解后得20-表人参二醇(20-epiproto panaxo-diol)皂甙元。又自乙醚提取物的低沸点部分分离出β-榄香烯(β-elemene,C15H24)。高沸点部分分离出人参炔醇(panaxynol,C17H260)。此外尚含有单糖类:葡萄糖、果糖、蔗醣,三种三糖:葡萄糖-果糖-果糖、三聚葡萄糖,葡萄糖-葡萄糖-果糖,人参酸(为软脂酸、硬脂酸及亚油酸的混和物),多钟维生素(B1、B2、菸酸、菸酰胺、泛酸),多种氨基酸、胆碱、酶(麦芽糖酶、转化酶、酯酶),精胺(spermine)及胆胺(cholamine)。人参的地上部分含黄酮类化合物,人称人参黄甙(panasenoside)、三叶甙(trifolin)、山柰醇、人参皂甙、β-谷甾醇及糖类。
检测方法:HPLC
产品性状:黄白色粉末
药理作用:
1.人参对中枢神经系统具有兴奋作用,而大量时反而有抑制作用。能加强动物高级神经活动的兴奋和抑制过程。并能增强机体对一切非特异性刺激的适应能力,能减少疲劳感(人参的根、茎、叶均能延长小白鼠游泳的持续时间)。
2.人参对心肌及血管有直接作用,一般在小剂量时兴奋,大剂量时抑制。10%人参浸液1毫升/公斤给猫(或兔)灌胃,对心肌无力有一定的改善作用。复温期间有相当程度的恢复。亦有抗过敏性休克及强心的作用。人参对大鼠心肌细胞膜三磷酸腺苷酶活性有抑制作用。
3.加强机体对有害因素的抵抗力:
(1)能使感染疟原虫的鸡免于急性死亡,且鸡的体重还逐渐增加。
(2)能抑制实验动物由于注射牛奶或疫苗所引起的发热反应。
(3)能增强人体适应气温变化的能力。
(4)狗在大量失血或窒息而处于垂危状态时,立即注射人参制剂,可使降至很低水平的血压稳固回升。
(5)能延长受锥虫感染的小鼠的存活时间。
(6)能抑制注射松节油或由于兔耳壳冻伤而引起的全身炎症反应。
(7)促进某些实验性损伤的愈合。(8)有抗维生素B1、B2缺乏症的作用。
(9)能加速家兔实验性角膜溃疡的愈合作用。
(10)能减弱某些毒物(苯、四乙铅、三甲酚磷酸等)对机体的作用。
4.对因肾上腺素引起的高血糖动物有降低血糖的作用;对糖尿病患者除能自觉改善症状外,还有轻微的降血糖作用,并与胰岛素有协同作用。
5.能促进动物的性腺功能,小白鼠吃小量人参,能产生举尾现象。
6.在适当剂量,对家兔也能增加体重,使血浆白蛋白与球蛋白的比值上升。
7.刺激造血器官,有改善贫血的作用。
8.长期服用小量,可使网状内皮系统即能亢进;剂量过大,则呈相反作用。
9、西红花提取物(Saffron extract)
植物来源:藏红花属于鸢尾科多年生球茎花卉
规格:总红花苷10%
主要成分含番红花苷(crocin)-1、番红花苷-2、番红花苷-3、番红花苷-4、反式和顺式番红花二甲酯(trans-,cis-crocetindimethyLester)、α-,β-胡萝卜素、α-番红花酸(α-crocetin)、玉米黄质、番茄红素、番红花苦甙(picrocrocin)。另含挥发油0.4%-1.3%,油中主要含番红花醛(safranal),为番红花苦甙的分解产物,其次含桉油精、蒎烯等;此外含异鼠李素、山柰素及维生素B1和维生素B2。
检测方法:HPLC
产品性状:黄棕色粉末
药理作用:西红花萃取物二甲基藏红花酸对白血病、卵巢癌、结肠癌、横纹肌肉瘤、结肠癌、乳头肉瘤、扁平细胞瘤和软组织肉瘤等都具有较强的抑制作用。其抗癌机理可能是破坏DNA合成酶系,即破坏了对细胞DNA合成至关重要的DNA-蛋白质联系媒介,从而抑制DNA和RNA的合成,达到抑制肿瘤细胞生长的作用。
煎剂可使麻醉狗、猫血压降低,并能维持较长时间;对呼吸还有兴奋作用。降压时肾容积缩小,显示肾血管收缩;对蟾蜍血管亦呈收缩作用。在离体蟾蜍心脏上有较显著的抑制作用。有人对它作为手术过程中使心跳暂停的药物进行了探讨,发现水浸剂在离体蟾蜍、大鼠心脏、急性猫在位心脏标本上,均能导致心脏的迅速完全停跳于舒张期,历时达十数分钟以上,且极易恢复;如与乙酰胆碱同用,则停跳更迅速而完全。复跳时无纤颤发生,复跳后心脏活动均形加强。但经化学分析,抑制心脏的成分与钾盐有关,此点颇堪注意,盖番红花中既含多量钾盐,而钾盐不仅可抑制心脏,引起降压,对平滑肌如小肠、子宫、支气管、血管等的紧张度及收缩亦均具兴奋作用,因此今后番红花之药理研究应首先除去钾盐。
下面结合实施例对本发明进一步说明。
实施例1:
(1)生命素组分
其成分重量百分比如下:
蓝莓提取物 12%
欧荨麻提取物 6%
苦参总碱提取物 4%
印度水芹提取物 14%
薄荷提取物 4%
生姜提取物 7%
野葛根提取物 10%
人参提取物 7%
西红花提取物 5%
纯净水 31%
将上述组分的原料混合,在常温下搅拌1分钟,使其充分混合,制成生命素。
使用方法为在1000g温水中加入5g上述配方的生命素为宠物洗澡,充分按摩、轻触皮毛5分钟。
(2)实验对象
两只1岁、中毛的可卡犬,其中1号犬用清水洗浴,2号犬用实施例1所述配方的生命素洗浴,喂养食物、方法、环境等相同。
(3)实验结果
由以上实验结果看出,使用该生命素的2号犬只比用清水洗浴的1号犬只脱毛情况及毛质情况明显改善。
实施例2:
(1)生命素组分
其成分重量百分比如下:
蓝莓提取物 10%
欧荨麻提取物 5%
苦参总碱提取物 2%
印度水芹提取物 10%
薄荷提取物 2%
生姜提取物 5%
野葛根提取物 8%
人参提取物 5%
西红花提取物 3%
纯净水 50%
将上述组分的原料混合,在常温下搅拌1分钟,使其充分混合制成生命素。
使用方法为在1000g温水中加入5g上述配方的生命素为宠物洗澡,充分按摩、轻触皮毛5分钟。
(2)实验对象
两只1.1岁、长毛的北京犬,其中1号犬用清水洗浴,2号犬用实施例2所述配方的生命素洗浴,喂养食物、方法、环境等相同。
(3)实验结果
由以上实验结果看出,使用该生命素的2号犬只比用清水洗浴的1号犬只脱毛情况及毛质情况明显改善。
实施例3:
(1)生命素组分
其成分重量百分比如下:
蓝莓提取物 14%
欧荨麻提取物 8%
苦参总碱提取物 6%
印度水芹提取物 13%
薄荷提取物 5%
生姜提取物 8%
野葛根提取物 10%
人参提取物 9%
西红花提取物 7%
纯净水 20%
将上述组分的原料混合,在常温下搅拌1分钟,使其充分混合制成生命素。
使用方法为在1000g温水中加入5g上述配方的生命素为宠物洗澡,充分按摩、轻触皮毛5分钟。
(2)实验对象
两只2岁、长毛的西施犬,其中1号犬用清水洗浴,2号犬用实施例3所述配方的生命素洗浴,喂养食物、方法、环境等相同。
(3)实验结果
由以上实验结果看出,使用该生命素的2号犬只比用清水洗浴的1号犬只脱毛情况及毛质情况明显改善。
实施例4:
(1)生命素组分
其成分重量百分比如下:
蓝莓提取物 11%
欧荨麻提取物 6%
苦参总碱提取物 6%
印度水芹提取物 10%
薄荷提取物 5%
生姜提取物 5%
野葛根提取物 9%
人参提取物 8%
西红花提取物 5%
纯净水 35%
将上述组分的原料混合,在常温下搅拌1分钟,使其充分混合制成生命素。
使用方法为在1000g温水中加入5g上述配方的生命素为宠物洗澡,充分按摩、轻触皮毛5分钟。
(2)实验对象
两只1.5岁、长毛的博美犬,其中1号犬用清水洗浴,2号犬用实施例4所述配方的生命素洗浴,喂养食物、方法、环境等相同。
(3)实验结果
由以上实验结果看出,使用该生命素的2号犬只比用清水洗浴的1号犬只脱毛情况及毛质情况明显改善。
以上四组实验均以犬类作为实验对象,而由于猫的皮肤组织结构、毛发和犬的皮肤组织结构、毛发相同,因此,本发明的生命素同样适用于猫类。
另外,为了能使该生命素有较长的保质期,可以在其中加入重量百分比为0.1-0.3%的防腐剂,优选的重量百分比为0.1%,该防腐剂可以为山梨酸钾或者苯甲酸钠等。实验证明,在本发明的生命素中加入重量百分比为0.1%的山梨酸钾或者苯甲酸钠防腐剂,保质期可以达到36个月以上。
本发明的犬猫防脱生命素,能全面清洁毛发、杀虫、杀菌、除螨、止痒,通过促进狗、猫皮肤的血液循环,全面补充毛囊、毛发、皮肤所需的营养物质,提高皮肤、毛囊、毛发的免疫力,降低抗过敏性,增强皮肤、毛囊、毛发的修复功能,起到预防、治疗犬、猫类非正常脱毛的目的,通过实验证明,该生命素对犬类的非正常脱毛具有很好的抑制作用,而且能使毛质顺滑、光泽,由于本发明的配方均为天然植物提取物,不包含任何的工业化工成分,对犬、猫不会产生任何副作用。
Claims (6)
1、一种犬猫防脱生命素,其特征在于其组分的重量百分比如下:
蓝莓提取物 10-14%
欧荨麻提取物 5-8%
苦参总碱提取物 2-6%
印度水芹提取物 10-15%
薄荷提取物 2-5%
生姜提取物 5-8%
野葛根提取物 8-12%
人参提取物 5-9%
西红花提取物 3-7%
加纯净水至100%。
2、根据权利要求1所述的一种犬猫防脱生命素,其特征在于其组分的重量百分比如下:
蓝莓提取物 12%
欧荨麻提取物 6%
苦参总碱提取物 4%
印度水芹提取物 14%
薄荷提取物 4%
生姜提取物 7%
野葛根提取物 10%
人参提取物 7%
西红花提取物 5%
加纯净水至100%。
3、根据权利要求1或2所述的一种犬猫防脱生命素,其特征在于它还包括重量百分比为0.1-0.3%的防腐剂。
4、根据权利要求3所述的一种犬猫防脱生命素,其特征在于所述防腐剂的重量百分比为0.1%。
5、根据权利要求3所述的一种犬猫防脱生命素,其特征在于所述防腐剂为山梨酸钾或者苯甲酸钠。
6、根据权利要求4所述的一种犬猫防脱生命素,其特征在于所述防腐剂为山梨酸钾或者苯甲酸钠。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100410819A CN101623245B (zh) | 2009-07-14 | 2009-07-14 | 犬猫防脱毛洗液 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100410819A CN101623245B (zh) | 2009-07-14 | 2009-07-14 | 犬猫防脱毛洗液 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101623245A true CN101623245A (zh) | 2010-01-13 |
CN101623245B CN101623245B (zh) | 2011-07-20 |
Family
ID=41519340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100410819A Expired - Fee Related CN101623245B (zh) | 2009-07-14 | 2009-07-14 | 犬猫防脱毛洗液 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101623245B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106619309A (zh) * | 2017-01-09 | 2017-05-10 | 杭州科润生物科技有限公司 | 一种宠物护理剂及其制备方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1739481A (zh) * | 2005-09-15 | 2006-03-01 | 邹菲 | 宠物猫狗除臭、驱除寄生虫及防脱毛专用香水的制作方法 |
-
2009
- 2009-07-14 CN CN2009100410819A patent/CN101623245B/zh not_active Expired - Fee Related
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106619309A (zh) * | 2017-01-09 | 2017-05-10 | 杭州科润生物科技有限公司 | 一种宠物护理剂及其制备方法 |
CN106619309B (zh) * | 2017-01-09 | 2020-03-27 | 杭州科润生物科技有限公司 | 一种宠物护理剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN101623245B (zh) | 2011-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103652361A (zh) | 一种产后1-20天哺乳期母猪饲料及其制备方法 | |
KR101744103B1 (ko) | 탈모방지 및 발모촉진용 조성물 및 그의 제조방법 | |
KR101244302B1 (ko) | 탈모에 효과적인 건강보조식품 및 그 제조방법 | |
KR20160087112A (ko) | 꽃차 및 이의 제조방법 | |
KR20160087113A (ko) | 꽃을 함유하는 화장품 | |
CN105125466A (zh) | 一种祛斑晚霜及其制备方法 | |
CN110354204B (zh) | 一种具有明目功效的组合物及其制备、应用方法 | |
CN103478508A (zh) | 用于提高鸡免疫力的中药组合物、饲料及其制备方法 | |
JP2014522832A (ja) | 発毛促進剤及び製造方法 | |
CN103041042B (zh) | 一种藏药组合物及其在防脱生发产品中的应用 | |
JP6463504B2 (ja) | 発毛促進、脱毛緩和及び改善、血糖調節、胃腸障害の症状緩和及び改善用健康補助食品 | |
CN105232907A (zh) | 一种补肾壮阳饮料及其制备方法 | |
CN105132219A (zh) | 一种淡化萎缩纹的香皂及其制备方法 | |
CN109430856A (zh) | 一种养护眼睛改善视疲劳的保健食品配方及其制备方法 | |
CN103948541B (zh) | 一种黑加仑黑发洗发液的制备方法 | |
CN113133957A (zh) | 一种植物发酵提拉紧致抗氧化抗疲劳眼贴膜及其制备方法 | |
CN106333897A (zh) | 一种含辣木活性成分的修复精华液及其制备方法 | |
CN101623245A (zh) | 犬猫防脱生命素 | |
CN104970223A (zh) | 一种牛配合饲料及其制备方法 | |
CN103301357A (zh) | 一种促进乌发中药制剂的配方及制备方法 | |
CN103845628B (zh) | 一种用于治疗猫破伤风的药物及其制备方法 | |
CN102266427A (zh) | 一种用于美容养颜的鹿茸当归酒及其制备方法和应用 | |
CN106727245B (zh) | 一种清热保湿护唇膏及其制备方法 | |
DE202008002263U1 (de) | Gesundheitsförderndes Mittel und dessen Verwendung | |
CN105342923A (zh) | 一种预防嘴唇干裂的唇膏及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110720 Termination date: 20150714 |
|
EXPY | Termination of patent right or utility model |